Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Elan to market Dainippon's zonisamide in North America

May 15, 1997

Glutamate antagonists from Warner-Lambert

May 15, 1997

MS&D discloses 5-HT1-like receptor agonists

May 15, 1997

MS&D describes tachykinin antagonists

May 15, 1997

ET antagonists from Warner-Lambert claimed for cerebrovascular disorders

May 15, 1997

CollaGenex promotes Ponstel for short-term dental pain relief

May 14, 1997

New antimigraine agents from Merck Sharp & Dohme

May 14, 1997

Forest submits NDA for antidepressant

May 13, 1997

CRF receptor antagonist from Pfizer active in animal model of depression

May 13, 1997

FDA advisory committee votes against Myotrophin approval

May 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...